Tongling Jieya Biologic Technology Co. Ltd.

301108 · SHE · Consumer Defensive / Household & Personal Products

41.83CNY-2.11 (-4.80%)

Price History

Full chart

Market Stats

Previous Close43.94

Open43.94

Day Range41.50 – 44.35

52-Week Range21.17 – 56.56

Volume1.35M

Market Cap5.77B

P/E (TTM)78.82

Forward P/E0.00

EPS0.65

Dividend Yield0.53%

Beta0.26

50-Day Avg39.48

200-Day Avg31.89

About

Tongling Jieya Biologic Technology Co., Ltd. engages in the research and development, production, and sale of wet wipe products in China. The company provides dry and wet wipes, including baby wipes, wet toilet paper, personal care wipes, dry towels, antibacterial and disinfecting wipes, and home cleaning wet towel products. It also offers beauty care products, such as emollient water, lotion, cream, essence, facial masks, makeup removers, and body and hair care products, as well as products for children, including baby lotion, baby cream, baby oil, and baby shower gel. The company was founded in 1999 and is based in Tongling, China.

Company Details

SectorConsumer Defensive
IndustryHousehold & Personal Products
CEOMr. Yingchuan Cai
Employees634
HeadquartersNo. 528, Geology Avenue, Tongling, China, 244031, China
Websitehttps://www.babywipes.com.cn

Leadership

Mr. Yingchuan CaiChairman of the Board & GM · b. 1969
Mr. Fanlong YangCFO, Accounting Supervisor & Director · b. 1988
Ms. Ying YeDeputy GM & Director · b. 1976
Mr. Nenghua HuDeputy GM & Board Secretary · b. 1968
Mr. Xiang-Kui ZhaiDeputy General Manager · b. 1981

Financials

Income Statement

Currency: CNY	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	277.43M	743.01M	984.45M	666.56M	622.59M	547.45M	772.01M
Growth (%)	-	+167.82%	+32.49%	-32.29%	-6.60%	-12.07%	+41.02%
Cost of Revenue	176.03M	477.09M	661.20M	456.83M	438.15M	439.98M	575.65M
Gross Profit	101.40M	265.92M	323.25M	209.74M	184.44M	107.47M	196.36M
Gross Margin	36.55%	35.79%	32.84%	31.47%	29.62%	19.63%	25.43%
Operating Expense	27.13M	44.08M	69.71M	63.52M	78.59M	75.02M	95.00M
Operating Income	74.27M	221.83M	253.54M	146.22M	105.85M	32.44M	101.36M
Operating Margin	26.77%	29.86%	25.75%	21.94%	17.00%	5.93%	13.13%
EBITDA	92.32M	221.84M	284.28M	198.43M	175.07M	72.66M	139.80M
EBITDA Margin	33.28%	29.86%	28.88%	29.77%	28.12%	13.27%	18.11%
Net Income	68.12M	179.63M	220.05M	140.97M	115.20M	19.46M	77.27M
Net Income Margin	24.55%	24.18%	22.35%	21.15%	18.50%	3.56%	10.01%
R&D	10.89M	27.36M	36.38M	25.29M	22.52M	20.48M	28.19M
R&D as % of Total Revenue	3.92%	3.68%	3.70%	3.79%	3.62%	3.74%	3.65%
Interest Expense	27.22K	613.17K	1.62M	1.86M	1.01M	769.02K	1.39M
Interest Expense % of Total Revenue	0.01%	0.08%	0.16%	0.28%	0.16%	0.14%	0.18%

Balance Sheet

Currency: CNY	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	394.39M	874.76M	2.05B	2.07B	2.15B	2.08B	2.33B
Total Liabilities	130.19M	433.21M	359.10M	287.73M	289.82M	253.60M	446.44M
Total Equity	264.20M	441.55M	1.69B	1.78B	1.86B	1.83B	1.88B
Cash	137.17M	321.35M	1.42B	1.00B	665.16M	403.81M	649.22M

Cash Flow

Currency: CNY	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	106.87M	187.56M	200.18M	299.02M	83.51M	75.12M	99.17M
Capital Expenditure	29.34M	103.20M	72.59M	29.91M	85.05M	96.23M	367.95M
Free Cash Flow	77.53M	84.36M	127.59M	269.10M	-1.54M	-21.11M	-268.78M
Dividends Paid	30.65M	3.03M	263.36K	60.91M	40.60M	29.16M	19.30M
FCF to OCF	72.54%	44.98%	63.74%	90.00%	-1.84%	-28.11%	-271.03%
Dividend Paid to FCF	39.54%	3.59%	0.21%	22.63%	-2641.70%	-138.12%	-7.18%

Earnings

Report Date	Dec 31, 2021	Apr 27, 2022	Aug 27, 2022	Oct 28, 2022	Apr 19, 2023	Aug 29, 2023	Oct 30, 2023	Apr 15, 2024	Aug 28, 2024	Oct 29, 2024	Apr 24, 2025	Aug 28, 2025	Oct 24, 2025	Apr 29, 2026	Aug 31, 2026
EPS Estimate	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EPS Actual	0.31	0.58	0.51	0.49	0.15	0.34	0.35	0.27	0.11	0.10	0.13	0.20	0.31	0.09	0.28
Surprise	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Timing	-	After-hours	Pre-market	After-hours	Pre-market	Pre-market	After-hours	Pre-market	-	Pre-market	Pre-market	-	-	-	-

Key Statistics & Ratios

Market Cap5.77B

Enterprise Value4.89B

Trailing P/E78.82

Forward P/E0.00

Price / Sales6.55

Price / Book3.03

EPS0.65

Book Value17.01

Revenue (TTM)880.78M

Gross Profit (TTM)206.71M

EBITDA131.85M

Profit Margin9.80%

Operating Margin6.32%

Return on Equity4.58%

Return on Assets2.25%

Shares Outstanding112.56M

Shares Float36.61M

Beta0.26

Dividend Yield0.53%

Dividend Rate0.27

Payout Ratio39.48%

Dividends

20262×

0.12Sep 11, 20260.15May 20, 2026

20252×

0.10Sep 26, 20250.07Jul 10, 2025

20241×

0.26Jun 13, 2024

20231×

0.36May 26, 2023

20221×

0.54May 23, 2022

Stock Splits

Jul 10, 20251.4:1